Find clinical trials for medical research studies worldwide.
A study comparing obrixtamig (an immune therapy) combined with standard chemotherapy versus standard chemotherapy alone for people with advanced neuroendocrine cancer outside the lungs
Status: Recruiting — Phase: Phase 3 — Start:
Conditions: Extrapulmonary Neuroendocrine Cancer (epNEC)
View Study Details →Testing how well zongertinib is tolerated when combined with standard chemotherapy, with or without pembrolizumab, in people with advanced lung cancer that has a HER2 mutation
Status: Recruiting — Phase: Phase 2 — Start:
Conditions: Lung Cancer, Non-squamous, Non-small Cell
View Study Details →A safety study testing AMG 436 cancer treatment alone and with other therapies in people with specific types of solid tumors
Status: Recruiting — Phase: Phase 1 — Start:
Conditions: Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR)
View Study Details →A research study testing a new cancer treatment called MT-304, given alone or with nivolumab, in adults with advanced cancers that have a protein called HER2
Status: Recruiting — Phase: Phase 1 — Start:
Conditions: HER2-Expressing Solid Tumors
View Study Details →A study testing a new cancer drug called EIK1005, given alone or combined with pembrolizumab, in people with advanced solid tumors including MSI-H tumors
Status: Recruiting — Phase: Phase 1,Phase 2 — Start:
Conditions: Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors, MSI-H/dMMR Gastric Cancer, MSI-H/dMMR Colorectal Cancer, MSI-H/dMMR Gastroesophageal-junction Cancer, Endometrial Cancer, Mismatch Repair Deficient or MSI-High Solid Tumors
View Study Details →A Phase 1 study testing a new cancer drug BG-75098 by itself and combined with other drugs in patients with advanced solid tumors
Status: Recruiting — Phase: Phase 1 — Start:
Conditions: Advanced Solid Tumor
View Study Details →A study comparing zongertinib to standard treatment in people who had early-stage lung cancer with HER2 gene changes removed by surgery
Status: Recruiting — Phase: Phase 3 — Start:
Conditions: Non-small Cell Lung Cancer
View Study Details →A first-in-human study testing new experimental cancer treatments BNT3212 and BNT327 in patients with advanced solid tumors who have tried other treatments
Status: Recruiting — Phase: Phase 1,Phase 2 — Start:
Conditions: Advanced Solid Tumor
View Study Details →A Clinical Study to Test the Safety and Potential Benefits of an Investigational Treatment Called BNT326, Alone or in Combination, for People With Advanced Cancers
Status: Recruiting — Phase: Phase 1,Phase 2 — Start:
Conditions: Advanced Solid Tumor
View Study Details →A study evaluating the safety and effectiveness of an investigational drug called MOMA-341 in patients with advanced or metastatic solid tumors
Status: Recruiting — Phase: Phase 1 — Start:
Conditions: Advanced Solid Tumor, Metastatic Solid Tumor, Endometrial Cancer, MSI-H Cancer, Colorectal Cancer, Gastric Cancer, dMMR Cancer
View Study Details →A study to evaluate the effectiveness and safety of olverembatinib in treating gastrointestinal stromal tumors (GIST) with SDH deficiency
Status: Recruiting — Phase: Phase 3 — Start:
Conditions: GIST
View Study Details →A study of an investigational drug called BG-C137 in people with advanced solid tumors
Status: Recruiting — Phase: Phase 1 — Start:
Conditions: Advanced Solid Tumor
View Study Details →A study evaluating the safety and effectiveness of a new drug called BGB-58067 in treating advanced solid tumors with a specific genetic defect
Status: Recruiting — Phase: Phase 1 — Start:
Conditions: Advanced Solid Tumor
View Study Details →A Clinical Study Evaluating the Efficacy and Safety of the Drug HLX22 in Combination with Trastuzumab and Chemotherapy for the Treatment of Gastric and Gastroesophageal Junction Cancer
Status: Recruiting — Phase: Phase 3 — Start:
Conditions: Gastroesophageal-junction Cancer, Monoclonal Antibody, Gastric Cancer, HER2-positive Gastric Cancer
View Study Details →Evaluating the efficacy of testosterone and darolutamide therapy in extending metastasis-free survival in non-metastatic castration-resistant prostate cancer patients
Status: Recruiting — Phase: Phase 2 — Start:
Conditions: Prostate Cancer
View Study Details →A Phase 1 study evaluating the safety and effectiveness of an investigational drug called YL211 in patients with advanced solid tumors
Status: Recruiting — Phase: Phase 1 — Start:
Conditions: Advanced Solid Tumors
View Study Details →A study to test the safety and effectiveness of an investigational oral drug, NST-628, in patients with advanced solid tumors
Status: Recruiting — Phase: Phase 1 — Start:
Conditions: Oncology, MEK Mutation, RAF Gene Mutation, Ras (KRAS or NRAS) Gene Mutation, Melanoma, NSCLC, Glioma, Solid Tumor, Adult, MAPK Pathway Gene Mutation
View Study Details →A trial of palliative chemotherapy, radiation, and immune treatment for advanced esophageal cancer
Status: Recruiting — Phase: Phase 2 — Start:
Conditions: Esophageal Cancer
View Study Details →A study evaluating the effectiveness of ivosidenib compared to a placebo in treating advanced or metastatic conventional chondrosarcoma
Status: Recruiting — Phase: Phase 3 — Start:
Conditions: Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
View Study Details →A study evaluating the safety and effectiveness of an investigational oral drug called RO7589831 for treating advanced solid tumors with specific genetic mutations
Status: Recruiting — Phase: Phase 1 — Start:
Conditions: Advanced Solid Tumors, Colorectal Cancer
View Study Details →